Pre-eclampsia and the placenta

Placenta

Volumn 12, Issue 4, 1991, Pages 301-308

  Redman, C W G ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ARTERY; FEMALE; HISTOLOGY; HUMAN; ISCHEMIA; PATHOPHYSIOLOGY; PLACENTA; PREECLAMPSIA; PREGNANCY; REVIEW; VASCULARIZATION; ATHEROSCLEROSIS; DIET; ECLAMPSIA; EMBRYO; FETUS; HYPERTENSION; INTRAUTERINE GROWTH RETARDATION; NONHUMAN; PATHOLOGY; PLACENTA CIRCULATION; PRIORITY JOURNAL; PROTEINURIA; TROPHOBLAST;

ANIMAL; ARTERIES; FEMALE; HUMAN; ISCHEMIA; PLACENTA; PRE-ECLAMPSIA; PREGNANCY;

ADENINE NUCLEOTIDE; ALKALINE PHOSPHATASE PLACENTA ISOENZYME; CHORIONIC GONADOTROPIN; CORTICOTROPIN RELEASING FACTOR; HUMAN PLACENTA LACTOGEN; LACTIC ACID; PROGESTERONE; PROSTACYCLIN; PYRUVIC ACID; THROMBOXANE; TOCOPHEROL;

EID: 0026198207     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/0143-4004(91)90339-H     Document Type: Article

References (107)

1. Production of experimental toxemia in the pregnant dog
2. Origins and significance of the increased plasma alkaline phosphatase during normal pregnancy and pre-eclampsia
3. Electron microscopic study of the trophoblast in normal and toxemic placentas
4. Toxemia-like syndromes in animals spontaneous and experimental
5. Embolism to the lungs by trophoblast
6. Eclampsia in a lowland gorilla
7. The natural history of choriocarcinoma; problems of immunity and spontaneous regression
8. Serum heat-stable alkaline phosphatase in pregnancy complicated by hypertension
9. Irreversible uterine and renal changes induced by placental ischemia (rabbit)
10. Deportation of trophoblast in the chinchilla
11. Placental glycolysis and energy metabolism in preeclampsia
12. Metabolic toxemia of late pregnancy — a disease of malnutrition
13. Fetal growth retardation and the arteries of the placental bed
14. A study of the spiral arteries of the decidua basalis in normotensive and hypertensive pregnancies
15. The role of the spiral arteries in the pathogenesis of preeclampsia
16. On the pathogenesis of placental infarcts in pre-eclampsia
17. Aetiology of pre-eclampsic toxaemia and eclampsia. Fact and theory
18. Histogenesis of pathological processes in placentas of metabolic disease in pregnancy. I. Toxemia and hypertension
19. Maternal vascular prostacyclin activity in pre-eclampsia
20. Qualitative assessment of uteroplacental blood flow: early screening test for high-risk pregnancies
21. Experimental toxemia in the pregnant primate
22. Trophoblast deportation in pre-eclamptic pregnancy
23. Clinical observations on some aspects of hydatiform moles
24. Aortic hypoplasia and its significance in the aetiology of pre-eclamptic toxaemia
25. Placental-type plasminogen activator inhibitor in preeclampsia
26. Fetal growth retardation and the maternal arterial supply of the human placenta in the absence of sustained hypertension
27. Rejection processes in human homotransplanted kidneys
28. Choriodecidual and myometrial blood-flow
29. Trophoblast in the circulating blood during pregnancy
30. Kinetics of prostacyclin synthetase in umbilical artery microsomes from normal and pre-eclamptic pregnancies
31. Changes in the plasma levels of type 1 and type 2 plasminogen activator inhibitors in normal pregnancy and in patients with severe preeclampsia
32. Blood progesterone levels in abnormal pregnancies
33. Toxemia of pregnancy in sheep: a clinical, physiological and pathological study
34. Decreased prostacyclin biosynthesis preceding clinical manifestations of pregnancy-induced hypertension
35. the placenta in maternal disorders
36. The villous cytotrophoblast as an index of placental ischaemia
37. Metabolic clearance rate of dehydroisoandrosterone sulfate VI. Studies of eclampsia
38. Tissue metabolism in experimental toxemia of pregnancy
39. Pre-eclampsia associated with hypoplasia of the aorta
40. An experimental study of the effect of ischaemia of the pregnant uterus on the blood pressure
41. Postpartum eclampsia treated by curettage
42. Renin in experimental “toxemia of pregnancy”
43. Experimental hypertensive disease of pregnancy
44. A model of pre-eclampsia including renal histology, in the baboon
45. Intervillous blood oxygen studies
46. Placental proteins 12 and 14 in pre-eclampsia
47. Lipid peroxidation in pregnancy: new perspectives on preeclampsia
48. Amelioration of the hypertension of toxemia by postpartum curettage
49. Elevated circulating levels of a decidual protein, placental protein 12, in preeclampsia
50. Occurrence of trophoblasts in the blood of toxaemic patients
51. The value of Doppler assessment of the uteroplacental circulations in predicting preeclampsia or intrauterine growth retardation
52. Some observations on the placental factor in pregnancy toxemia
53. Diffusion of radioactive sodium in normotensive and pre-eclamptic pregnancies
54. Intervillous blood flow in normal and complicated late pregnancy measured by means of an intravenous 133Xe method
55. Effects of thromboxane synthetase inhibition on maternal-fetal homeostasis in gravid ewes with ovine pregnancy-induced hypertension
56. Defective haemochorial placentation as a cause of miscarriage: a preliminary study
57. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants
58. Chronic placental ischemia in relation to the toxemias of pregnancy
59. Immunohistochemical findings in acute atherosis associated with intrauterine growth retardation
60. Human placental lactogen levels in pre-eclampsia
61. Placental infarction
62. Calcium supplementation reduces the risk of pregnancy-induced hypertension in an Andes population
63. Chorionic gonadotrophin in toxaemias of pregnancy
64. The ultrastructure of human trophoblast in spontaneous and induced hypoxia using a system of organ culture
65. Increased thromboxane A2 production but normal prostacyclin by the placenta in hypertensive pregnancies
66. Experimental eclampsia. An electron microscope study and review
67. Human placental lactogen in pre-eclampsia
68. A possible preventive effect of low-dose fish oil on early delivery and pre-eclampsia: indications from a 50-year-old controlled trial
69. The relation between hydatid moles, relative ischemia of the gravid uterus, and the placental origin of eclampsia
70. Placental dysfunction in eclamptogenic toxemias
71. On the pathogenesis of pre-eclampsia and eclampsia
72. Hormone production during pregnancy in the primigravid patient. I. Plasma levels of progesterone and 5-alpha-pregnane-3,20-dione throughout pregnancy of normal women and women who developed pregnancy-induced hypertension
73. The nutrition of expectant and nursing mothers in relation to maternal and infant mortality and morbidity
74. The kidney in toxemia of pregnancy: a clinical and pathologic study based on renal biopsies
75. Hypertension in pregnancy
76. Platelets and the beginnings of preeclampsia
77. Preeclampsia: an endothelial cell disorder
78. The pathological response of the vessels of the placental bed to hypertensive pregnancy
79. Uteroplacental vascular pathology
80. Postpartum curettement for hypertension
81. Preeclampsia is associated with a serum factor cytotoxic to human endothelial cells
82. Beta-human chorionic gonadotrophin levels before and after the development of pre-eclampsia
83. Postpartum eclampsia
84. Pregnancy toxaemia associated with hydrops foetalis hydatidiform mole and hydramnios
85. True pregnancy toxemia (pre-eclampsia) in the guinea pig (Cavia porcellus)
86. Ultrastructural aspects of preeclampsia. I. Placental bed and uterine boundary vessels
87. Decreased prostacyclin production: a characteristic of chronic placental insufficiency syndromes
88. Serum levels of placenta-specific tissue protein 12 (PP12) in pregnancies complicated by pre-eclampsia, diabetes or twins
89. Placental hypotheses
90. The continual migration of syncytial trophoblasts from the fetal placenta into the maternal circulation
91. Accommodation of the human placenta to hypoxia
92. The pathogenesis of placental infarction. I. A morphologic study in the human placenta
93. Placental prostacyclin production in normal and toxemic pregnancies
94. Increased progesterone may cause decreased placental prostacyclin production in preeclampsia
95. Progesterone and estradiol production by normal and preeclamptic placentas
96. Role of fibrin in a model of pregnancy toxemia in the rabbit
97. Placental infarction and toxemia of pregnancy
98. Plasma corticotrophin-releasing factor (CRF) in abnormal pregnancy
99. 6-keto prostaglandin F1-alpha, thromboxane B2, and 13,14,dihydro-15-keto prostaglandin F concentrations of normotensive and preeclamptic patients during pregnancy, and the postpartum period
100. Amniotic fluid prostacyclin and thromboxane in normal, pre-eclamptic, and some other complicated pregnancies
101. Placental plasminogen activator activity in pre-eclampsia
102. Recurrent pregnancy toxaemia and its relations to placental damage
103. The aetiology of eclampsia and albuminuria and their relation to accidental haemorrhage (an anatomical and experimental investigation)
104. Vascular changes in the decidua associated with eclamptogenic toxemia of pregnancy
105. Altered platelet calcium metabolism as an early predictor of increased peripheral vascular resistance and preeclampsia in urban black women
106. Potassium transport in kidney and placenta in normal pregnancy and in experimental toxemia